European Journal of Cancer
Volume 46, Issue 3 , Pages 599-605 , February 2010

Cancer incidence among Iranian immigrants in Sweden and Iranian residents compared to the native Swedish population

  • Seyed Mohsen Mousavi

      Affiliations

    • Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
    • Corresponding Author InformationCorresponding author: Tel.: +49 62 21421805; fax: +49 62 21421810.
    • ,
  • Andreas Brandt

      Affiliations

    • Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
    • ,
  • Marianne Weires

      Affiliations

    • Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
    • ,
  • Jianguang Ji

      Affiliations

    • Center for Primary Care Research, Lund University, Malmö, Sweden
    • ,
  • Jan Sundquist

      Affiliations

    • Center for Primary Care Research, Lund University, Malmö, Sweden
    • Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, CA, USA
    • ,
  • Kari Hemminki

      Affiliations

    • Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
    • Center for Primary Care Research, Lund University, Malmö, Sweden
    • Center for Family and Community Medicine, Karolinska Institute, 14183 Huddinge, Sweden

Received 13 July 2009 ,Revised 28 September 2009 ,Accepted 7 October 2009.

References 

  1. Ferlay JBF, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide. IARC CancerBase. Lyon, France: IARC Press; 2002;
  2. Hemminki K, Lorenzo Bermejo J, Forsti A. The balance between heritable and environmental aetiology of human disease. Nat Rev Genet. 2006;7(12):958–965
  3. Parkin DM, Khlat M. Studies of cancer in migrants: rationale and methodology. Eur J Cancer. 1996;32A(5):761–771
  4. Hemminki K, Li XJ, Czene K. Cancer risks in first-generation immigrants to Sweden. Int J Cancer. 2002;99(2):218–228
  5. Hemminki K, Li XJ. Cancer risks in second-generation immigrants to Sweden. Int J Cancer. 2002;99(2):229–237
  6. Hemminki K, Vaittinen P. National database of familial cancer in Sweden. Genet Epidemiol. 1998;15(3):225–236
  7. Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J. The Swedish family-cancer database 2009: prospects for histology-specific and immigrant studies. Int J Cancer. 2009;
  8. Hemminki K, Li X, Plna K, Granstrom C, Vaittinen P. The nation-wide Swedish family-cancer database – updated structure and familial rates. Acta Oncol. 2001;40(6):772–777
  9. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20(3):556–563
  10. Mousavi SM, Somi MH. Gastric cancer in Iran 1966–2006. Asian Pac J Cancer Prev. 2009;10(3):407–412
  11. Kamangar F, Malekzadeh R, Dawsey SM, Saidi F. Esophageal cancer in Northeastern Iran: a review. Arch Iran Med. 2007;10(1):70–82
  12. Ansari R, Mahdavinia M, Sadjadi A, et al. Incidence and age distribution of colorectal cancer in Iran: results of a population-based cancer registry. Cancer Lett. 2006;240(1):143–147
  13. Mousavi SM, Montazeri A, Mohagheghi MA, et al. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13(4):383–391
  14. The National Board of Health and Welfare. Cancer incidence in Sweden 2006. cited. Available from: <http://www.socialstyrelsen.se/Statistik/statistik_amne/Cancer>.
  15. In:  Boyle P,  Levin B editor. World Cancer Report 2008. Lyon: IARC; 2008;
  16. Yavari P, Hislop TG, Bajdik C, et al. Comparison of cancer incidence in Iran and Iranian immigrants to British Columbia, Canada. Asian Pac J Cancer Prev. 2006;7(1):86–90
  17. Siassi F, Pouransari Z, Ghadirian P. Nutrient intake and esophageal cancer in the Caspian littoral of Iran: a case–control study. Cancer Detect Prev. 2000;24(3):295–303
  18. Islami F, Kamangar F, Nasrollahzadeh D, et al. Socio-economic status and oesophageal cancer: results from a population-based case–control study in a high-risk area. Int J Epidemiol. 2009;38(4):978–988
  19. Akbari MR, Malekzadeh R, Nasrollahzadeh D, et al. Familial risks of esophageal cancer among the Turkmen population of the Caspian littoral of Iran. Int J Cancer. 2006;119(5):1047–1051
  20. Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol. 2005;11(8):1200–1203
  21. Hajiani E, Masjedizadeh R, Hashemi J, Azmi M, Rajabi T. Risk factors for hepatocellular carcinoma in Southern Iran. Saudi Med J. 2005;26(6):974–977
  22. Moghaddam SJ, Haghighi EN, Samiee S, et al. Immunohistochemical analysis of p53, cyclinD1, RB1, c-fos and N-ras gene expression in hepatocellular carcinoma in Iran. World J Gastroenterol. 2007;13(4):588–593
  23. Merat S, Rezvan H, Nouraie M, et al. The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med. 2009;12(3):225–231
  24. Christenson B, Bottiger M, Grillner L. The prevalence of hepatitis B in Sweden; a statistical serosurvey of 3381 Swedish inhabitants. Epidemiol Infect. 1997;119(2):221–225
  25. Soderstrom A, Lindh M, Eriksson K, et al. Chronic hepatitis B in children in Gothenburg, Sweden. Scand J Infect Dis. 1999;31(2):109–114
  26. Mousavi SM. Toward prostate cancer early detection in Iran. Asian Pac J Cancer Prev. 2009;10(3):413–418
  27. Kjellman A, Akre O, Norming U, Tornblom M, Gustafsson O. 15-year followup of a population based prostate cancer screening study. J Urol. 2009;181(4):1615–1621discussion 21
  28. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening – a population-based register study (Sweden). Cancer Causes Control. 2002;13(1):73–82
  29. Warnberg F, Bergh J, Zack M, Holmberg L. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case–control study in Sweden. Cancer Epidemiol Biomarkers Prev. 2001;10(5):495–499
  30. Hosseini SY, Safarinejad MR, Amini E, Hooshyar H. Opium consumption and risk of bladder cancer: a case–control analysis. Urol Oncol. 2008;
  31. Mohseni M, Zand S, Aghamir S. Effect of smoking on prognostic factors of transitional cell carcinoma of the bladder. Urol J. 2004;1(4):250–252
  32. Koochek A, Mirmiran P, Azizi T, et al. Is migration to Sweden associated with increased prevalence of risk factors for cardiovascular disease?. Eur J Cardiovasc Prev Rehabil. 2008;15(1):78–82
  33. Alikhani S, Delavari A, Alaedini F, Kelishadi R, Rohbani S, Safaei A. A province-based surveillance system for the risk factors of non-communicable diseases: a prototype for integration of risk factor surveillance into primary healthcare systems of developing countries. Public Health. 2009;123(5):358–364
  34. Mosavi-Jarrahi A, Mohagheghi M, Yazdizadeh B, Kolahi AA, Tahmasebi S, Sharifi S. Analysis of smoking behaviour among Iranian population: a cohort and period analysis. Asian Pac J Cancer Prev. 2004;5(1):66–69
  35. Moradi T, Nordqvist T, Allebeck P, Galanti MR. Risk of thyroid cancer among Iranian immigrants in Sweden. Cancer Causes Control. 2008;19(3):221–226

PII: S0959-8049(09)00756-4

doi: 10.1016/j.ejca.2009.10.009

European Journal of Cancer
Volume 46, Issue 3 , Pages 599-605 , February 2010

Article Tools

* Image Usage & Resolution